scorecardresearch
Saturday, April 20, 2024
Support Our Journalism
HomeIndiaModi govt asks Serum Institute, Bharat Biotech to lower prices of Covid...

Modi govt asks Serum Institute, Bharat Biotech to lower prices of Covid vaccines

The move comes after many states objected to different pricing of the vaccines, with Delhi CM Arvind Kejriwal saying this is not time for profiteering.

Follow Us :
Text Size:

New Delhi: The central government on Monday asked the Serum Institute and Bharat Biotech to lower prices of their COVID-19 vaccines amid criticism from various states who objected to profiteering during such a major crisis.

The issue of vaccine pricing was discussed at a meeting chaired by Cabinet Secretary Rajiv Gauba.

Now the two companies are expected to come up with revised pricing for their vaccines.

The Hyderabad-based Bharat Biotech has fixed the price of its COVID-19 vaccine, Covaxin, at Rs 600 per dose for state governments and at Rs 1,200 per dose for private hospitals.

The Pune-based Serum Institute of India (SII), the world’s largest vaccine maker in terms of volume, has announced a price of Rs 400 per dose for its COVID-19 vaccine, ‘Covishield’, for state governments and Rs 600 per dose for private hospitals.

Both vaccines are available to the central government at a rate of Rs 150 per dose.

Many states have objected to different prices of the vaccines, with Delhi Chief Minister Arvind Kejriwal saying this is not time for profiteering.

India has announced expansion of its COVID-19 vaccination drive by allowing its large 18-plus population to get inoculated from May 1.


Also read: Wear masks at home too, follow Covid protocol if you have symptoms but test negative, govt says


 

Subscribe to our channels on YouTube, Telegram & WhatsApp

Support Our Journalism

India needs fair, non-hyphenated and questioning journalism, packed with on-ground reporting. ThePrint – with exceptional reporters, columnists and editors – is doing just that.

Sustaining this needs support from wonderful readers like you.

Whether you live in India or overseas, you can take a paid subscription by clicking here.

Support Our Journalism

3 COMMENTS

  1. The value of these vaccines far exceeds the highest price (Rs. 1200). India should stop complaining about pricing and incentivize production. Without profits, there is no motive for private industry to solve India’s problems. Its amazing how Indians want the best solutions but don’t want to pay for them. You don’t get good solutions if you are not willing to pay for them. So get real India!

  2. Why should the central government wait for pressure from states to interfere on such an issue. Why is it that they cannot proactively interfere to regulate the price of vaccines and ensure an equitable distribution of vaccine? Or are you waiting for Manmohan Singh to send you another letter on what you should do next?

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular